Skip to main content
Erschienen in: European Journal of Nutrition 7/2018

07.09.2017 | Original Contribution

Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review

verfasst von: Yong-Jiang Li, Ya-Min Li, Da-Xiong Xiang

Erschienen in: European Journal of Nutrition | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Nutritional supplements have been used for correction of deficiencies that may occur in patient with autism spectrum disorder (ASD) and to improve core symptoms. We aim to provide current best evidence about supplements for nutritional deficiencies and core symptoms in children with ASD and to evaluate the effectiveness and safety.

Methods

A systematic literature search of scientific databases was performed to retrieve relevant randomized controlled trials. Risk of bias was assessed for each study.

Results

18 randomized controlled trials of five supplements were included. B6/Mg was not helpful for improving ASD symptoms (seven RCTs). Two RCTs of methyl B12 reported some improvement in ASD severity but the effects on the correction of deficiencies were inconclusive. Two RCTs of vitamin D3 both reported increased levels of mean 25(OH)D in serum but inconsistent results in behavioral outcomes. Omega-3 fatty acid supplementation did not affect ASD behaviors but may correct deficiencies (six RCTs). One RCT of folinic acid reported positive results in improving ASD symptoms measured by various behavioral scales.

Conclusions

Current evidence for the use of supplements for correcting nutritional deficiencies in children with ASD and to improve the symptoms is little. More studies are needed.
Literatur
1.
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub, Arlington, Virginia American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub, Arlington, Virginia
3.
Zurück zum Zitat Packer A (2016) Neocortical neurogenesis and the etiology of autism spectrum disorder. Neurosci Biobehav Rev 64:185–195CrossRefPubMed Packer A (2016) Neocortical neurogenesis and the etiology of autism spectrum disorder. Neurosci Biobehav Rev 64:185–195CrossRefPubMed
4.
Zurück zum Zitat Dawson G, Rice CE (2016) The complex etiology of autism presents challenges in risk communication. Pediatrics 137(2):1–2 Dawson G, Rice CE (2016) The complex etiology of autism presents challenges in risk communication. Pediatrics 137(2):1–2
5.
6.
Zurück zum Zitat Chang Y-C, Laugeson EA, Gantman A, Ellingsen R, Frankel F, Dillon AR (2014) Predicting treatment success in social skills training for adolescents with autism spectrum disorders: The UCLA Program for the Education and Enrichment of Relational Skills. Autism 18(4):467–470CrossRefPubMed Chang Y-C, Laugeson EA, Gantman A, Ellingsen R, Frankel F, Dillon AR (2014) Predicting treatment success in social skills training for adolescents with autism spectrum disorders: The UCLA Program for the Education and Enrichment of Relational Skills. Autism 18(4):467–470CrossRefPubMed
7.
Zurück zum Zitat Bishop-Fitzpatrick L, Minshew NJ, Eack SM (2014) A systematic review of psychosocial interventions for adults with autism spectrum disorders. In:Volkmar FR, Reichow B, McPartland JC (eds) Adolescents and adults with autism spectrum disorders. Springer, New York, pp 315–327CrossRef Bishop-Fitzpatrick L, Minshew NJ, Eack SM (2014) A systematic review of psychosocial interventions for adults with autism spectrum disorders. In:Volkmar FR, Reichow B, McPartland JC (eds) Adolescents and adults with autism spectrum disorders. Springer, New York, pp 315–327CrossRef
8.
Zurück zum Zitat McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-VanderWeele J (2011) A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127(5):e1312–e1321CrossRefPubMed McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-VanderWeele J (2011) A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127(5):e1312–e1321CrossRefPubMed
9.
Zurück zum Zitat Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY (2016) Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics 137(Supplement 2):S124–S135CrossRefPubMed Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY (2016) Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics 137(Supplement 2):S124–S135CrossRefPubMed
10.
Zurück zum Zitat Benevides TW, Carretta HJ, Mandell DS (2016) Differences in perceived need for medical, therapeutic, and family support services among children with ASD. Pediatrics 137(Supplement 2):S176–S185CrossRefPubMed Benevides TW, Carretta HJ, Mandell DS (2016) Differences in perceived need for medical, therapeutic, and family support services among children with ASD. Pediatrics 137(Supplement 2):S176–S185CrossRefPubMed
11.
Zurück zum Zitat Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L (2015) Core symptoms of autism improved after vitamin D supplementation. Pediatrics 135(1):e196–e198CrossRefPubMed Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L (2015) Core symptoms of autism improved after vitamin D supplementation. Pediatrics 135(1):e196–e198CrossRefPubMed
12.
Zurück zum Zitat Cannell JJ (2017) Vitamin D and autism, what’s new? Rev Endocr Metab Disord 18(2):183–193CrossRefPubMed Cannell JJ (2017) Vitamin D and autism, what’s new? Rev Endocr Metab Disord 18(2):183–193CrossRefPubMed
13.
Zurück zum Zitat Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC (2016) Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLoS One 11(1):e0146797CrossRefPubMedPubMedCentral Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC (2016) Decreased brain levels of vitamin B12 in aging, autism and schizophrenia. PLoS One 11(1):e0146797CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ranjan S, Nasser JA (2015) Nutritional status of individuals with autism spectrum disorders: do we know enough? Adv Nutr Int Rev J 6(4):397–407CrossRef Ranjan S, Nasser JA (2015) Nutritional status of individuals with autism spectrum disorders: do we know enough? Adv Nutr Int Rev J 6(4):397–407CrossRef
15.
Zurück zum Zitat Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C, Chalon S (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids (PLEFA) 65(1):1–7CrossRef Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C, Chalon S (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids (PLEFA) 65(1):1–7CrossRef
16.
Zurück zum Zitat Wiest M, German JB, Harvey DJ, Watkins S, Hertz-Picciotto I (2009) Plasma fatty acid profiles in autism: a case-control study. Prostaglandins Leukot Essent Fatty Acids 80(4):221–227CrossRefPubMed Wiest M, German JB, Harvey DJ, Watkins S, Hertz-Picciotto I (2009) Plasma fatty acid profiles in autism: a case-control study. Prostaglandins Leukot Essent Fatty Acids 80(4):221–227CrossRefPubMed
17.
Zurück zum Zitat Al-Farsi YM, Waly MI, Deth RC, Al-Sharbati MM, Al-Shafaee M, Al-Farsi O, Al-Khaduri MM, Gupta I, Ali A, Al-Khalili M (2013) Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition 29(3):537–541CrossRefPubMed Al-Farsi YM, Waly MI, Deth RC, Al-Sharbati MM, Al-Shafaee M, Al-Farsi O, Al-Khaduri MM, Gupta I, Ali A, Al-Khalili M (2013) Low folate and vitamin B12 nourishment is common in Omani children with newly diagnosed autism. Nutrition 29(3):537–541CrossRefPubMed
18.
Zurück zum Zitat Karin I, Borggraefe I, Catarino CB, Kuhm C, Hoertnagel K, Biskup S, Opladen T, Blau N, Heinen F, Klopstock T (2017) Folinic acid therapy in cerebral folate deficiency: marked improvement in an adult patient. J Neurol. doi:10.1007/s00415-016-8387-6 CrossRefPubMed Karin I, Borggraefe I, Catarino CB, Kuhm C, Hoertnagel K, Biskup S, Opladen T, Blau N, Heinen F, Klopstock T (2017) Folinic acid therapy in cerebral folate deficiency: marked improvement in an adult patient. J Neurol. doi:10.​1007/​s00415-016-8387-6 CrossRefPubMed
20.
Zurück zum Zitat Taylor JL, Dove D, Veenstra-VanderWeele J, Sathe NA, McPheeters ML, Jerome RN, Warren Z (2012) Interventions for adolescents and young adults with autism spectrum disorders. AHRQ Publication, Rockville Taylor JL, Dove D, Veenstra-VanderWeele J, Sathe NA, McPheeters ML, Jerome RN, Warren Z (2012) Interventions for adolescents and young adults with autism spectrum disorders. AHRQ Publication, Rockville
21.
Zurück zum Zitat Weitlauf AS, Sathe N, McPheeters ML, Warren ZE (2017) Interventions targeting sensory challenges in autism spectrum disorder: a systematic review. Pediatrics 139(6):e20170347CrossRefPubMed Weitlauf AS, Sathe N, McPheeters ML, Warren ZE (2017) Interventions targeting sensory challenges in autism spectrum disorder: a systematic review. Pediatrics 139(6):e20170347CrossRefPubMed
22.
Zurück zum Zitat Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M (1997) High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disord 27(4):467–478CrossRefPubMed Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M (1997) High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study. J Autism Dev Disord 27(4):467–478CrossRefPubMed
23.
Zurück zum Zitat Lelord G, Muh J, Barthelemy C, Martineau J, Garreau B, Callaway E (1981) Effects of pyridoxine and magnesium on autistic symptoms—initial observations. J Autism Dev Disord 11(2):219–230CrossRefPubMed Lelord G, Muh J, Barthelemy C, Martineau J, Garreau B, Callaway E (1981) Effects of pyridoxine and magnesium on autistic symptoms—initial observations. J Autism Dev Disord 11(2):219–230CrossRefPubMed
24.
Zurück zum Zitat Martineau J, Barthelemy C, Garreau B, Lelord G (1985) Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism. Biol Psychiatry 20(5):467–478CrossRefPubMed Martineau J, Barthelemy C, Garreau B, Lelord G (1985) Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism. Biol Psychiatry 20(5):467–478CrossRefPubMed
25.
Zurück zum Zitat Tolbert L, Haigler T, Waits MM, Dennis T (1993) Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. J Autism Dev Disord 23(1):193–199CrossRefPubMed Tolbert L, Haigler T, Waits MM, Dennis T (1993) Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. J Autism Dev Disord 23(1):193–199CrossRefPubMed
26.
Zurück zum Zitat Bertoglio K, Jill James S, Deprey L, Brule N, Hendren RL (2010) Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med 16(5):555–560CrossRefPubMed Bertoglio K, Jill James S, Deprey L, Brule N, Hendren RL (2010) Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med 16(5):555–560CrossRefPubMed
27.
Zurück zum Zitat Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S (2016) Randomized, placebo-controlled trial of methyl B12 for children with autism. J Child Adolesc Psychopharmacol 26(9):774–783CrossRefPubMed Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S (2016) Randomized, placebo-controlled trial of methyl B12 for children with autism. J Child Adolesc Psychopharmacol 26(9):774–783CrossRefPubMed
28.
Zurück zum Zitat Saad K, Abdel‐Rahman AA, Elserogy YM, Al‐Atram AA, El‐Houfey AA, Othman HA, Bjørklund G, Jia F, Urbina MA, Abo‐Elela MGM (2016) Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry. doi:10.1111/jcpp.12652 CrossRefPubMed Saad K, Abdel‐Rahman AA, Elserogy YM, Al‐Atram AA, El‐Houfey AA, Othman HA, Bjørklund G, Jia F, Urbina MA, Abo‐Elela MGM (2016) Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry. doi:10.​1111/​jcpp.​12652 CrossRefPubMed
30.
Zurück zum Zitat Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61(4):551–553CrossRefPubMed Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61(4):551–553CrossRefPubMed
31.
Zurück zum Zitat Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL (2011) A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord 41(5):545–554CrossRefPubMed Bent S, Bertoglio K, Ashwood P, Bostrom A, Hendren RL (2011) A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord 41(5):545–554CrossRefPubMed
32.
Zurück zum Zitat Bent S, Hendren RL, Zandi T, Law K, Choi J-E, Widjaja F, Kalb L, Nestle J, Law P (2014) Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry 53(6):658–666CrossRefPubMedPubMedCentral Bent S, Hendren RL, Zandi T, Law K, Choi J-E, Widjaja F, Kalb L, Nestle J, Law P (2014) Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry 53(6):658–666CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, Jensen CL, Barbaresi WJ (2014) Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr 58(6):715–722PubMed Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, Jensen CL, Barbaresi WJ (2014) Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr 58(6):715–722PubMed
35.
Zurück zum Zitat Yui K, Koshiba M, Nakamura S, Kobayashi Y (2012) Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial. J Clin Psychopharmacol 32(2):200–206CrossRefPubMed Yui K, Koshiba M, Nakamura S, Kobayashi Y (2012) Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial. J Clin Psychopharmacol 32(2):200–206CrossRefPubMed
36.
Zurück zum Zitat Frye R, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S (2016) Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. doi:10.1038/mp.2016.168 CrossRefPubMedPubMedCentral Frye R, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, Sailey A, Wynne R, Rose S, Melnyk S (2016) Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. doi:10.​1038/​mp.​2016.​168 CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Dosman CF, Brian JA, Drmic IE, Senthilselvan A, Harford MM, Smith RW, Sharieff W, Zlotkin SH, Moldofsky H, Roberts SW (2007) Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol 36(3):152–158CrossRefPubMed Dosman CF, Brian JA, Drmic IE, Senthilselvan A, Harford MM, Smith RW, Sharieff W, Zlotkin SH, Moldofsky H, Roberts SW (2007) Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol 36(3):152–158CrossRefPubMed
38.
Zurück zum Zitat Sun C, Zou M, Zhao D, Xia W, Wu L (2016) Efficacy of folic acid supplementation in autistic children participating in structured teaching: an open-label trial. Nutrients 8(6):337CrossRefPubMedCentral Sun C, Zou M, Zhao D, Xia W, Wu L (2016) Efficacy of folic acid supplementation in autistic children participating in structured teaching: an open-label trial. Nutrients 8(6):337CrossRefPubMedCentral
39.
Zurück zum Zitat Gabriele S, Sacco R, Persico AM (2014) Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol 24(6):919–929CrossRefPubMed Gabriele S, Sacco R, Persico AM (2014) Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis. Eur Neuropsychopharmacol 24(6):919–929CrossRefPubMed
40.
Zurück zum Zitat Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K (2010) Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 67(1):59–68CrossRefPubMed Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K (2010) Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 67(1):59–68CrossRefPubMed
41.
Zurück zum Zitat Berger A, Schaumburg H (1984) More on neuropathy from pyridoxine abuse. N Engl J Med 311(15):986–987PubMed Berger A, Schaumburg H (1984) More on neuropathy from pyridoxine abuse. N Engl J Med 311(15):986–987PubMed
42.
Zurück zum Zitat Fine KD, Santa Ana CA, Fordtran JS (1991) Diagnosis of magnesium-induced diarrhea. N Engl J Med 324(15):1012–1017CrossRefPubMed Fine KD, Santa Ana CA, Fordtran JS (1991) Diagnosis of magnesium-induced diarrhea. N Engl J Med 324(15):1012–1017CrossRefPubMed
43.
Zurück zum Zitat James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80(6):1611–1617CrossRefPubMed James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80(6):1611–1617CrossRefPubMed
44.
Zurück zum Zitat James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW (2009) Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 89(1):425–430CrossRefPubMed James SJ, Melnyk S, Fuchs G, Reid T, Jernigan S, Pavliv O, Hubanks A, Gaylor DW (2009) Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr 89(1):425–430CrossRefPubMed
45.
Zurück zum Zitat Kalinina E, Chernov N, Novichkova M (2014) Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochemistry (Moscow) 79(13):1562–1583CrossRef Kalinina E, Chernov N, Novichkova M (2014) Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochemistry (Moscow) 79(13):1562–1583CrossRef
46.
Zurück zum Zitat Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F (2016) Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 25(4):341–350CrossRefPubMed Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F (2016) Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 25(4):341–350CrossRefPubMed
49.
Zurück zum Zitat Huang Y-N, Ho Y-J, Lai C-C, Chiu C-T, Wang J-Y (2015) 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflamm 12(1):147CrossRef Huang Y-N, Ho Y-J, Lai C-C, Chiu C-T, Wang J-Y (2015) 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflamm 12(1):147CrossRef
50.
Zurück zum Zitat Patrick RP, Ames BN (2014) Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 28(6):2398–2413CrossRefPubMed Patrick RP, Ames BN (2014) Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 28(6):2398–2413CrossRefPubMed
51.
Zurück zum Zitat Castro K, Klein LdS, Baronio D, Gottfried C, Riesgo R, Perry IS (2016) Folic acid and autism: what do we know? Nutr Neurosci 19(7):310–317CrossRefPubMed Castro K, Klein LdS, Baronio D, Gottfried C, Riesgo R, Perry IS (2016) Folic acid and autism: what do we know? Nutr Neurosci 19(7):310–317CrossRefPubMed
52.
Zurück zum Zitat Delmelle F, Thöny B, Clapuyt P, Blau N, Nassogne M-C (2016) Neurological improvement following intravenous high-dose folinic acid for cerebral folate transporter deficiency caused by FOLR-1 mutation. Eur J Paediatr Neurol 20(5):709–713CrossRefPubMed Delmelle F, Thöny B, Clapuyt P, Blau N, Nassogne M-C (2016) Neurological improvement following intravenous high-dose folinic acid for cerebral folate transporter deficiency caused by FOLR-1 mutation. Eur J Paediatr Neurol 20(5):709–713CrossRefPubMed
53.
Zurück zum Zitat Yehuda S, Rabinovitz S, Mostofsky D (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 26(1):98–102CrossRefPubMed Yehuda S, Rabinovitz S, Mostofsky D (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 26(1):98–102CrossRefPubMed
54.
Zurück zum Zitat Mazahery H, Stonehouse W, Delshad M, Kruger MC, Conlon CA, Beck KL, von Hurst PR (2017) Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: systematic review and meta-analysis of case–control and randomised controlled trials. Nutrients 9(2):155CrossRefPubMedCentral Mazahery H, Stonehouse W, Delshad M, Kruger MC, Conlon CA, Beck KL, von Hurst PR (2017) Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: systematic review and meta-analysis of case–control and randomised controlled trials. Nutrients 9(2):155CrossRefPubMedCentral
55.
Zurück zum Zitat Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, Van der Oord S, Döpfner M (2013) Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170(3):275–289CrossRefPubMed Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, Van der Oord S, Döpfner M (2013) Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170(3):275–289CrossRefPubMed
56.
Zurück zum Zitat Chen AT, Chibnall JT, Nasrallah HA (2016) A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: possible stage-specific effects. Ann Clin Psychiatry 27(4):289–296 Chen AT, Chibnall JT, Nasrallah HA (2016) A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: possible stage-specific effects. Ann Clin Psychiatry 27(4):289–296
57.
Zurück zum Zitat Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F (2014) Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 9(5):e96905CrossRefPubMedPubMedCentral Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, Drago F, Caraci F (2014) Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 9(5):e96905CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat James SJ, Melnyk S, Jernigan S, Hubanks A, Rose S, Gaylor DW (2008) Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. J Autism Dev Disord 38(10):1966–1975CrossRefPubMedPubMedCentral James SJ, Melnyk S, Jernigan S, Hubanks A, Rose S, Gaylor DW (2008) Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. J Autism Dev Disord 38(10):1966–1975CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Heinrichs SC (2010) Dietary ω-3 fatty acid supplementation for optimizing neuronal structure and function. Mol Nutr Food Res 54(4):447–456CrossRefPubMed Heinrichs SC (2010) Dietary ω-3 fatty acid supplementation for optimizing neuronal structure and function. Mol Nutr Food Res 54(4):447–456CrossRefPubMed
Metadaten
Titel
Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review
verfasst von
Yong-Jiang Li
Ya-Min Li
Da-Xiong Xiang
Publikationsdatum
07.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 7/2018
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-017-1528-6

Weitere Artikel der Ausgabe 7/2018

European Journal of Nutrition 7/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.